Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Arctic Bioscience Logo
Arctic Bioscience Growth Score
42
CB Rank
169348
Heat Score
61
Arctic Bioscience is a biotech company that produces bioactive marine-based pharmaceutical and nutraceutical products and solutions.
Founded
obfuscation
PublicPost-IPO Debt Ørsta, More og Romsdal, Norway11-50 www.arctic-bioscience.com
Biopharma
Biotechnology
Medical
Pharmaceutical
Overview

Arctic Bioscience
Total Funding
obfuscation
Growth Score
42
Heat Score
61

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score42
-15 pts
in past quarter
Heat Score 61
-24 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Arctic Bioscience

CB Rank
169348
Arctic Bioscience is a biotech company that produces bioactive marine-based pharmaceutical and nutraceutical products and solutions.
Founded
obfuscation
PublicPost-IPO Debt Ørsta, More og Romsdal, Norway11-50 www.arctic-bioscience.com
Biopharma
Biotechnology
Medical
Pharmaceutical

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation

Key People

Details

Legal Name Arctic Bioscience AS
Operating Status Active
Stock Symbol  OSE:ABS
Company Type For Profit
Founders  Hogne Hallaråker
About the Company
Arctic Bioscience is a biotechnology research company that develops products, solutions, and technologies based on bioactive marine compounds that are either kept proprietary or patented. Their products include pharmaceutical development, B2B products, and romega branded products.
Phone Number +47 95293384
Contact Email contact@arctic-bioscience.com
Predictions & Insights

Growth Insight

See this Growth Insight
Arctic Bioscience is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

HRO350
An oral drug candidate developed for treating mild-to-moderate psoriasis by leveraging marine membrane lipids to reduce inflammation.
ROMEGA® Nutraceutical Products
Nutraceutical ingredients and finished products based on high DHA marine omega-3 phospholipid extracts and proteins derived from Norwegian herring roe.

Research & Development

Arctic Bioscience is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
obfuscation
— Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Photo of Asbjørn Solevågseide
Asbjørn Solevågseide
—
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
Photo of Asbjørn Solevågseide
Asbjørn Solevågseide
—
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
Photo of Asbjørn Solevågseide
Asbjørn Solevågseide
—
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
Photo of Asbjørn Solevågseide
Asbjørn Solevågseide
—
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
Photo of Asbjørn Solevågseide
Asbjørn Solevågseide
—
Post-IPO Debt - Arctic Bioscience Logo
Post-IPO Debt - Arctic Bioscience
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Board Members and Advisors 1 Contacts 6

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 8, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

812
34.44%
 in past month

IT Spend

$156.2KThis year, Arctic Bioscience is projected to spend $156.2K on IT, according to Aberdeen.

Active Website Tech Count

28Arctic Bioscience is actively using 28 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  Apple Mobile Web Clips Icon.

Total IP

7The intellectual property of Arctic Bioscience includes 4 registered patents primarily in the 'Foods Or Foodstuffs; Their Treatment, Not Covered By Other Classes' category, according to IPqwery. Additionally, Arctic Bioscience has registered 3 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Arctic Bioscience's headquarters? Arctic Bioscience is located in Ørsta, More og Romsdal, Norway.Who invested in Arctic Bioscience? Arctic Bioscience has 7 investors including Asbjørn Solevågseide and  Tore Tønseth.When was the last funding round for Arctic Bioscience? Arctic Bioscience closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Arctic Bioscience's competitors? Alternatives and possible competitors to Arctic Bioscience may include KD Pharma Group, InnoBio, and  Goerlich Pharma.How much funding has Arctic Bioscience raised to date? Arctic Bioscience has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|